Suspected ectopic pregnancy

Obstetrics and Gynecology

Volumn 107, Issue 2 I, 2006, Pages 399-413

  Seeber, Beata E ^b   Barnhart, Kurt T ^a  

^a Penn Fertility Care   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; FOLINIC ACID; METHOTREXATE; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROGESTERONE; VASCULOTROPIN; ABORTIVE AGENT;

ALOPECIA; BLOODY DIARRHEA; BODY WEIGHT DISORDER; BONE MARROW SUPPRESSION; CHEMOTHERAPY INDUCED EMESIS; CURETTAGE; DISEASE PREDISPOSITION; DIZZINESS; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MECHANISM; ECTOPIC PREGNANCY; ENTERITIS; FALLOPIAN TUBE PATENCY; FEMALE; FEMALE FERTILITY; FOLLOW UP; GASTRITIS; HIGH RISK POPULATION; HORMONE DETERMINATION; HUMAN; INFERTILITY THERAPY; INTRAPARTUM HEMORRHAGE; LAPAROSCOPIC SURGERY; LIVER DYSFUNCTION; MULTIPLE DRUG DOSE; NAUSEA; NEUTROPENIA; PELVIC INFLAMMATORY DISEASE; PELVIS PAIN SYNDROME; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SALPINGECTOMY; SALPINGOSTOMY; SINGLE DRUG DOSE; SMOKING; SPONTANEOUS ABORTION; STOMATITIS; SURGICAL INJURY; TRANSVAGINAL ECHOGRAPHY; UNRUPTURED ECTOPIC PREGNANCY; UTERINE TUBE DISEASE; UTERINE TUBE INJURY; WEIGHT REDUCTION; ALGORITHM; PREGNANCY;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ALGORITHMS; FEMALE; HUMANS; METHOTREXATE; PREGNANCY; PREGNANCY, ECTOPIC; RISK FACTORS;

EID: 33645457306     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000198632.15229.be     Document Type: Review

References (101)

1. Centers for Disease Control and Prevention. Current trends ectopic pregnancy - United States, 1990-1992. MMWR Morb Mortal Wkly Rep 1995;44:46-8.
2. Barnhart K, Esposito M, Coutifaris C. An update on the medical treatment of ectopic pregnancy. Obstet Gynecol Clin North Am 2000;27:653-67.
3. Fylstra DL. Tubal pregnancy: a review of current diagnosis and treatment. Obstet Gynecol Surv 1998;53:320-8.
4. Pisarska MD, Carson SA, Buster JE. Ectopic pregnancy. Lancet 1998;351:1115-20.
5. Washington AE, Katz P. Ectopic pregnancy in the United States: economic consequences and payment source trends. Obstet Gynecol 1993;81:287-92.
6. Yao M, Tulandi T. Current status of surgical and nonsurgical management of ectopic pregnancy. Fertil Steril 1997;67:421-33.
7. Maymon R, Shulman A. Controversies and problems in the current management of tubal pregnancy. Hum Reprod Update 1996;2:541-51.
8. Ankum WM, Mol BW, van der Veen F, Bossuyt PM. Risk factors for ectopic pregnancy: a meta-analysis. Fertil Steril 1996;65:1093-9.
9. Rossing MA, Daling JR, Voigt LF, Stergachis AS, Weiss NS. Current use of an intrauterine device and risk of tubal pregnancy. Epidemiology 1993;4:252-8.
10. Goddijn M van der Veen F, Schuring-Blom GH, Ankum WM, Leschot NJ. Cytogenetic characteristics of ectopic pregnancy. Hum Reprod 1996;11:2769-71.
11. Coste J, Fernandez H, Joye N, Benifla J, Girard S, Marpeau L, Job-Spira N. Role of chromosome abnormalities in ectopic pregnancy. Fertil Steril 2000;74:1259-60.
12. Attar E. Endocrinology of ectopic pregnancy. Obstet Gynecol Clin N Am 2004;31:779-94.
13. Bai SX, Wang YL, Qin L, Xiao ZJ, Herva R, Piao YS. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy. Reproduction 2005;129:103-13.
14. Della-Giustina D, Denny M. Ectopic Pregnancy. Emerg Med Clin North Am 2003;21:565-84.
15. Mol BW, Hajenius PJ, Ankum WM, Bossuyt PM, van der Veen F. Screening for ectopic pregnancy in symptom-free women at increased risk. Obstet Gynecol 1997;89:704-7.
16. Mol BW, van der Vee F, Bossuyt PM. Symptom-free women at increased risk of ectopic pregnancy: should we screen? Acta Obstet Gynecol Scand 2002;81:661-72.
17. Gracia CR, Barnhart KT. Diagnosing ectopic pregnancy: decision analysis comparing six strategies. Obstet Gynecol 2001;97:464-70.
18. Ahmed AA, Tom BD, Calabrese P. Ectopic pregnancy diagnosis and the pseudo-sac. Fertil Steril 2004;81:1125-8.
19. Barnhart K, Mennuti MT, Benjamin I, Jacobson S, Goodman D, Coutifaris C. Prompt diagnosis of ectopic pregnancy in an emergency department setting. Obstet Gynecol 1994;84:1010-5.
20. Barnhart KT, Katz I, Hummel A, Gracia CR. Presumed diagnosis of ectopic pregnancy. Obstet Gynecol 2002;100:505-10.
21. Lindahl B, Ahlgren M. Identification of chorion villi in abortion specimens. Obstet Gynecol 1986;67:79-81.
22. Barnhart KT, Gracia CR, Reindl B, Wheeler JE. Usefulness of pipelle endometrial biopsy in the diagnosis of women at risk for ectopic pregnancy [see comment]. Am J Obstet Gynecol 2003;188:906-9.
23. Barnhart KT, Sammel MD, Rinaudo PF, Zhou L, Hummel AC, Guo W. Symptomatic patients with an early viable intrauterine pregnancy; hCG curves redefined. Obstet Gynecol 2004;104:50-5.
24. Pittaway DE, Went AC. Evaluation of early pregnancy by serial chorionic gonadotropin determinations: a comparison of methods by receiver operator characteristic curve analysis. Fertil Steril 1985;43:529-33.
25. Fritz M, Guo S. Doubling time of human chorionic gonadotropin (hCG) in early normal pregnancy: relationship to hCG concentration and gestational age. Fertil Steril 1987;47:584-9.
26. Kadar N, Freedman M, Zacher M. Further observation on the doubling time of hCG in early asymptomatic pregnancies. Fertil Steril 1990;54:783-7.
27. Barnhart KT, Sammel MD, Chung K, Zhou L, Hummel AC, Guo W. Decline of serum hCG and spontaneous complete abortion: defining the normal curve. Obstet Gynecol 2004;104:975-81.
28. Ailawadi M, Lorch SA, Barnhart KT. Cost effectiveness of presumptively medically treating women at risk for ectopic pregnancy compared to first performing a dilatation and curettage. Fertil Steril 2004;83:376-82.
29. Stovall TG, Kellerman AL, Ling FW, Buster JE. Emergency department diagnosis of ectopic pregnancy. Ann Emerg Med 1990;19:1098-103.
30. Stovall TG, Ling FW, Andersen RN, Buster JE. Improved sensitivity and specificity of a single measurement of serum progesterone over serial quantitative beta-human chorionic gonadotrophin in screening for ectopic pregnancy. Hum Reprod 1992;7:723-5.
31. Stovall TG, Ling FW, Carson SA, Buster JE. Serum progesterone and uterine curettage in differential diagnosis of ectopic pregnancy. Fertil Steril 1992;57:456-8.
32. McCord ML, Muram D, Buster JE, Arheart KL, Stovall TG, Carson SA. Single serum progesterone as a screen for ectopic pregnancy: Exchanging specificity and sensitivity to obtain optimal test performance. Fertil Steril 1996;66:513-6.
33. Mol BW, Lijmer JG, Ankum WM, Van Der Veen F, Bossuyt PM. The accuracy of single serum progesterone measurement in the diagnosis of ectopic pregnancy: a meta-analysis. Hum Reprod 1998;13:3220-7.
34. Condous G, Lu C, Van Huffel SV, Timmerman D, Bourne T. Human chorionic gonadotrophin and progesterone levels in pregnancies of unknown location. Int J Gynaecol Obstet 2004;86:351-7.
35. Daniel Y, Geva E, Lerner-Geva L, Eshed-Englender T, Gamzu R, Lessing JB, et al. Levels of vascular endothelial growth factor are elevated in patients with ectopic pregnancy: is this a novel marker? Fertil Steril 1999;72:1013-7.
36. Fasouliotis SJ, Spandorfer SD, Witkin SS, Liu H-C, Roberts JE, Rosenwaks Z. Maternal serum vascular endothelial growth factor levels in early ectopic and intrauterine pregnancies after in vitro fertilization treatment. Fertil Steril 2004;82:309-13.
37. Mueller MD, Raio L, Spoerri S, Ghezzi F, Dreher E, Bersinger NA. Novel placental and nonplacental serum markers in ectopic versus normal intrauterine pregnancy. Fertil Steril 2004;81:1106-11.
38. Gerton GL, Fan XJ, Chittams J, Sammel M, Hummel A, Strauss JF, Barnhart K. A serum proteomics approach to the diagnosis of ectopic pregnancy. Ann N Y Acad Sci 2004;1022:306-16.
39. Vitoratos N, Gregoriou O, Papadias C, Konidaris S, Kalogirou D, Kalampokis D, et al. Clinical value of creatinine kinase in the diagnosis of ectopic pregnancy. Gynecol Obstet Invest 1998;46:80-3.
40. Saha PK, Gupta I, Ganguly NK. Evaluation of serum creatine kinase as a diagnostic marker for tubal pregnancy. Aust N Z J Obstet Gynaecol 1999;39:366-7.
41. Nowacek GE, Meyer WR, McMahon MJ, Thorp JR, Wells SR. Diagnostic value of cervical fetal fibronectin in detecting extrauterine pregnancy. Fertil Steril 1999;72:302-4.
42. Ness RB, McLaughlin MT, Heine RP, Bass DC, Mortimer L. Fetal fibronectin as a marker to discriminate between ectopic and intrauterine pregnancies. Am J Obstet Gynecol 1998;179:697-702.
43. Wegner NT, Mershon JL. Evaluation of leukemia inhibitory factors as a marker of ectopic pregnancy. Am J Obstet Gynecol 2001;184:1074-6.
44. Birkhahn RH, Gaeta TJ, Suzuki T, Katoh H, Nagai R, Bove J. Serum levels of smooth muscle heavy-chain myosin in patients with ectopic pregnancy. Ann Emerg Med 2000;36:101-7.
45. Predanic M. Differentiating tubal abortion from viable ectopic pregnancy with serum CA-125 and beta-human chorionic gonadotropin determinations. Fertil Steril 2000;73:522-5.
46. Mol BW, van der Veen F, Bossuyt PM. Implementation of probabilistic decision rules improves the predictive values of algorithms in the diagnostic management of ectopic pregnancy. Hum Reprod 1999;14:2855-62.
47. Condous G, Okaro E, Khalid A, Timmerman D, Lu C, Zhou Y, et al. The use of a new logistic regression model for predicting outcome of pregnancies of unknown location. Hum Reprod 2004;19:1900-10.
48. Buster JE, Carso SA. Ectopic pregnancy: new advances in diagnosis and treatment. Curr Opin Obstet Gynecol 1995;7:168-76.
49. Calabresi P, Chabner BA. Antineoplastic agents. In: Gilman A, Goodman LS, Goodman A, editors. The pharmacologic basis of therapeutics. 8th ed. New York (NY): Macmillan Publishing; 1990. p. 1275-6.
50. Berlin NI, Rall D, Mead JA, Freireich EJ, Van Scott E, Hertz R, et al. Folic acid antagonists: effects on the cell and the patient. Clinical staff conference at National Institutes of Health. Ann Intern Med 1963;59:931-56.
51. Lipscomb GH, Meyer NL, Flynn DE, Peterson M, Lin FW. Oral methotrexate for treatment of ectopic pregnancy. Am J Obstet Gynecol 2002;186:1192-5.
52. Stovall TG, Ling FW, Buster JE. Outpatient chemotherapy of unruptured ectopic pregnancy. Fertil Steril 1989;51:435-8.
53. Stovall TG, Ling FW. Single-dose methotrexate: an expanded clinical trial. Am J Obstet Gynecol 1993;168:1759-65.
54. Lipscomb GH, Bran D, McCord ML, Portera JC, Lin FW. Analysis of three hundred fifteen ectopic pregnancies treated with single-dose methotrexate. Am J Obstet. Gynecol 1998;178:1354-8.
55. Stovall TG, Ling FW, Gray LA, Carson SA, Buster JE. Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases. Obstet Gynecol 1991;77:749-53.
56. Tulandi T, Hemmings R, Khalifa F. Rupture of ectopic pregnancy in women with low and declining serum beta-human chorionic gonadotropin concentrations. Fertil Steril 1991;56:786-7.
57. Montgomery Irvine L, Padwick ML. Serial serum HCG measurements in a patient with an ectopic pregnancy: a case for caution. Hum Reprod 2000;15:1646-7.
58. Dudley PS, Heard MJ, Sangi-Haghpeykar H, Carson SA, Buster JE. Characterizing ectopic pregnancies that rupture despite treatment with methotrexate 2004;82:1374-8.
59. Hajenius PJ, Engelsbel S, Mol BW, van der Veen F, Ankum WM, Bossuyt PM, et al. Randomized trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy. Lancet 1997;350:774-9.
60. Henry MA, Gentry WL. Single injection of methotrexate for treatment of ectopic pregnancies. Am J Obstet Gynecol 1994;171:1584-7.
61. Glock JL, Johnson JV, Brumsted JR. Efficacy and safety of single-dose systemic methotrexate in the treatment of ectopic pregnancy. Fertil Steril 1994;62:716-21.
62. Lecuru F, Robin F, Bernard J-P, Maizan de Malartic C, Mac-Cordick C, Boucaya V, et al. Single-dose methotrexate for unruptured ectopic pregnancy. Int J Gynecol Obstet 1998;61:253-9.
63. Barnhart KT, Gosman G, Ashby R, Sammel M. The medical management of ectopic pregnancy: a meta-analysis comparing "single dose" and "multidose" regimens. Obstet Gynecol 2003;101:778-84.
64. Lipscomb GH, Stovall TG, Ling FW. Nonsurgical treatment of ectopic pregnancy. N Engl J Med 2000;343:1325-9.
65. Stika CS, Anderson L, Frederiksen MC. Single-dose methotrexate for the treatment of ectopic pregnancy: Northwestern Memorial Hospital three-year experience. Am J Obstet Gynecol 1996;174:1840-8.
66. American College of Obstetricians and Gynecologists. Medical management of tubal pregnancy. ACOG Practice Bulletin 3. Washington, DC: ACOG; 1998.
67. Tawfiq A, Agameya AF, Claman P. Predictors of treatment failure for ectopic pregnancy treated with single-dose methotrexate. Fertil Steril 2000;74:877-80.
68. Potter MB, Lepine LA, Jamieson DJ. Predictors of success with methotrexate treatment of tubal ectopic pregnancy at Grady Memorial Hospital. Am J Obstet Gynecol 2003;188:1192-4.
69. Elito J, Reichmann AP, Uchiyama MN, Camano L. Predictive score for the systemic treatment of unruptured ectopic pregnancy with a single dose of methotrexate. Int J Gynaecol Obstet 1999;67:75-9.
70. Lipscomb GH, McCord ML, Stovall TG, Huff G, Portera SG, Ling FW. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. N Engl J Med 1999;341:1974-8.
71. Lipscomb GH, Puckett KJ, Bran D, Ling FW. Management of separation pain after single-dose methotrexate therapy for ectopic pregnancy. Obstet Gynecol 1999;93:590-3.
72. Thompson GR, O'Shea RT, Harding A. Beta HCG levels after conservative treatment of ectopic pregnancy: is a plateau normal? Aust N Z J Obstet Gynecol 1994;34:96-8.
73. Atri M, Bret PM, Tulandi T, Senterman MK. Ectopic pregnancy: evolution after treatment with transvaginal methotrexate. Radiology 1992;185:749-53.
74. Ushakov FB, Elchalal U, Aceman PJ, Schenker JG. Cervical pregnancy: past and future. Obstet Gynecol Surv 1997;52:45-59.
75. Barnhart K, Spandorfer S, Coutifaris C. Is the medical management of an interstitial pregnancy safe? A report of three unsuccessful cases. J Reprod Med 1997;8:521-4.
76. Chelmow D, Gates E, Penzias AS. Laparoscopic diagnosis and methotrexate treatment of an ovarian pregnancy: a case report. Fertil Steril 1994;62:879-81.
77. Creinin MD, Washington AE. Cost of ectopic pregnancy management: surgery versus methotrexate. Fertil Steril 1993;60:963-9.
78. Alexander JM, Rouse DJ, Varner E, Austin JM Jr. Treatment of the small unruptured ectopic pregnancy: a cost analysis of methotrexate versus laparoscopy. Obstet Gynecol 1996;88:123-7.
79. Yao M, Tulandi TG, Kaplow M, Smith AP. A comparison of methotrexate versus laparoscopy for the treatment of ectopic pregnancy: a cost analysis. Hum Reprod 1996;11:2762-6.
80. Lecuru F, Robin F, Chasset S, Leonard F, Guitti S, Taurelle R. Direct cost of single dose methotrexate for unruptured ectopic pregnancy; prospective comparison with laparoscopy. Eur J Obstet Gynecol Reprod Biol 2000;88:1-6.
81. Morlock RJ, Lafata JE, Eisenstein D. Cost-effectiveness of single-dose methotrexate compared with laparoscopic treatment of ectopic pregnancy. Obstet Gynecol 2000;95:407-12.
82. Trout S, Kemmann E. Reversible alopecia after single-dose methotrexate treatment in a patient with ectopic pregnancy. Fertil Steril 1995;64:866-7.
83. Straka M, Zeringue E, Goldman M. A rare drug reaction to methotrexate after treatment for ectopic pregnancy. Obstet Gynecol 2004;103:1047-8.
84. Vermesh M, Silva PD, Rosen GF, Stein AL, Fossum GT, Sauer MN. Management of unruptured ectopic gestation by linear salpingostomy: a prospective, randomized clinical trial of laparoscopy versus laparotomy. Obstet Gynecol 1989;73:400-4.
85. Lundorff P, Thorburn J, Lindblom B. Fertility outcome after conservative surgical treatment of ectopic pregnancy evaluated in a randomized trial. Fertil Steril 1992;57:998-1002.
86. Murphy AA, Nager CW, Wujek JJ, Kettel LM, Torp VA, Chin HG. Operative laparoscopy versus laparotomy for the management of ectopic pregnancy: a prospective trial. Fertil Steril 1992;57:1180-5.
87. Hajenius PJ, Mol BW, Bossuyt PM, Ankum WM, Van der Veen F. Interventions for tubal ectopic pregnancy (Cochrane Review). In: The Cochrane Library 2, 2000. Oxford: Update Software.
88. Bangsgaard N, Lund CO, Ottesen B, Nilas L. Improved fertility following conservative surgical management of ectopic pregnancy. BJOG 2003;110:765-70.
89. DiMarchi JM, Kosasa TS, Kobara TY, Hale RW. Persistent ectopic pregnancy. Obstet Gynecol 1987;70:555-60.
90. Vermesh M, Silva PD, Sauer MV, Vargyas JM, Lobo RA. Persistent tubal ectopic gestation: patterns of circulating beta-human chorionic gonadotropin and progesterone, and management options. Fertil Steril 1988;50:584-8.
91. Seifer DB, Gutmann JN, Grant WD, Kamps CA, DeCherney AH. Comparison of persistent ectopic pregnancy after laparoscopic salpingostomy versus salpingectomy at laparotomy for ectopic pregnancy. Obstet Gynecol 1993;81:378-82.
92. Graczykowski JW, Mishell DR Jr. Methotrexate prophylaxis of persistent ectopic pregnancy after conservative treatment by salpingostomy. Obstet Gynecol 1997;89:118-22.
93. Gracia CR, Brown HA, Barnhart KT. Prophylactic methotrexate after linear salpingostomy: a decision analysis. Fertil Steril 2001;76:1191-5.
94. Mettler L. Pelvic adhesions: laparoscopic approach. Ann N Y Acad Sci 2003;997:255-68.
95. Farquhar C, Vandekerckhove P, Watson A, Vail A, Wiseman D. Barrier agents for preventing adhesions after surgery for subfertility (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford:Update Software.
96. Stovall TG, Ling FW, Buster JE. Reproductive performance after methotrexate treatment of ectopic pregnancy. Am J Obstet Gynecol 1990;162:1620-4.
97. Stovall TG. Medical management should be routinely used as primary therapy for ectopic pregnancy. Clin Obstet Gynecol 1995;38:346-52.
98. Butts S, Sammel M, Hummel A, Chittams J, Barnhart K. Risk factors and clinical features of recurrent ectopic pregnancy: a case control study. Fertil Steril 2003;80:1340-4.
99. Olofsson JI, Poromaa IS, Ottander U, Kjellberg L Damber MG. Clinical and pregnancy outcome following ectopic pregnancy; a prospective study comparing expectancy, surgery and systemic methotrexate treatment. Acta Obstet Gynecol Scand 2001;80:744-9.
100. Dias Pereira G, Hajenius PJ, Mol BW, Ankum WM, Hemrika DJ, Bossuyt PM, et al. Fertility outcome after systemic methotrexate and laparoscopic salpingostomy for tubal pregnancy. Lancet 1999;353:724-5.
101. Fernandez H, Yves Vincent SC, Pauthier S, Audibert F, Frydman R. Randomized trial of conservative laparoscopic treatment and methotrexate administration in ectopic pregnancy and subsequent fertility. Hum Reprod 1998;13:3239-43.